Jeroen C.H. van der Hilst

Author

Also Known As

Cem I Sungur, J C H Van der Hilst, J C H van der Hilst, J Van der Hilst, J van Hilst, J van der Hilst, J. C. H. Van Der Hilst, J. C. H. van der Hilst, J. VAN DER HILST, J. van der Hilst

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen Radboud University Medical Center Jessa Hospital Hasselt University University of Antwerp

About

Jeroen C.H. van der Hilst is an author at Radboud University Nijmegen specializing in medicine, public health, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	131
2	Public Health	3	3	103
3	Epidemiology	2	2	56
4	Biostatistics	1	1	47
5	Cell Biology	1	1	18

Jeroen C.H. van der Hilst

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes Fabrizio De Benedetti, Marco Gattorno, Jordi Antón, New England Journal of Medicine	2018	458
Long-Term Follow-Up, Clinical Features, and Quality of Life in a Series of 103 Patients With Hyperimmunoglobulinemia D Syndrome Jeroen C.H. van der Hilst, Evelien J. Bodar, Karyl S. Barron, Medicine	2008	397
Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model. E.J. Bodar, Jeroen C.H. van der Hilst, Joost P.H. Drenth, PubMed	2005	164
Hypogammaglobulinaemia: cumulative experience in 49 patients in a tertiary care institution. Jeroen C.H. van der Hilst, Bart W. Smits, J.W.M. van der Meer PubMed	2002	70
Anakinra as a diagnostic challenge and treatment option for systemic autoinflammatory disorders of undefined etiology Stephanie R Harrison, Dennis McGonagle, Sharmin Nizam, JCI Insight	2016	67
Risk factors for mortality in hospitalized patients with COVID-19 at the start of the pandemic in Belgium: a retrospective cohort study Karlijn van Halem, Robin Bruyndonckx, Jeroen C.H. van der Hilst, BMC Infectious Diseases	2020	61
Increased susceptibility of serum amyloid A 1.1 to degradation by MMP-1: potential explanation for higher risk of type AA amyloidosis Jeroen C.H. van der Hilst, Toshiyuki Yamada, Huub J. M. Op den Camp, Lara D. Veeken	2008	47
A Clinical Criterion to Exclude the Hyperimmunoglobulin D Syndrome (Mild Mevalonate Kinase Deficiency) in Patients with Recurrent Fever Olivier Steichen, Jeroen C.H. van der Hilst, Anna Simon, The Journal of Rheumatology Clinical CriterionGenetic TestingImmunodeficienciesImmunologyGenetic Epidemiology	2009	47
Managing a cluster outbreak of psittacosis in Belgium linked to a pet shop visit in The Netherlands Cindy De Boeck, Chantal Dehollogne, Marcel Spierenburg, Epidemiology and Infection Parasitic DiseaseDiagnosisDisease OutbreakPet Shop VisitClinical Epidemiology	2015	37
Defective apoptosis of peripheral-blood lymphocytes in hyper-IgD and periodic fever syndrome Evelien J. Bodar, Jeroen C.H. van der Hilst, Waander L. van Heerde, Blood	2006	36

Page 1